Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Rituximab May Slow Beta-Cell Destruction in Patients With Type 1 Diabetes - (DGNews)
    Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial - (BMJ)
    Glucose Intolerance During Pregnancy Associated With Postpartum Cardiovascular Risk - (DGNews)
    TopAbstracts in Diabetes 12/01/2009 - (DGNews)
    Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function - (N Engl J Med)

    News archive

     Recent webcasts/CME - Diabetes
      Clinical Practice In Type 2 Diabetes: After Metformin And Lifestyle, Then What?
      Diabetes and the Heart: Diabetes and Glycemic Control - Endocrine
      Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Diabetes and the Heart: Cardiometabolic Screening and Hospital Care
      Diabetes and the Heart: Diabetes and Glycemic Control - Cardiovascular

      Webcasts/CME archive

       Recent cases - Diabetes
        Transient Anti-GAD Antibody Positivity and Acute Pancreatitis with Pancreas Tail Swelling in a Patient with Susceptible Haplotype for Type 1 Diabetes Mellitus
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Insulin Lispro Injection Effective For Lowering Before-Dinner Blood Glucose In Type 1 Diabetes

        A DGReview of :"Efficacy of Humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes"
        Diabetic Medicine

        03/26/2003
        By James Adams


        An injection of insulin lispro prior to the afternoon meal effectively lowers before-dinner blood glucose levels in adolescents with type 1 diabetes.

        Investigators from the Hopital Necker-Enfants Malades in Paris, France, studied 43 boys and girls aged 12.4 ± 2.4 years with type 1 diabetes. Twenty patients were randomly assigned to receive an injection of insulin lispro while the 23 were assigned to a control group that received no injection.

        Both groups consumed identical meals for a two-month period. Mean before-dinner blood glucose was measured during the last two weeks of the study.

        Patients in the treatment group ate an afternoon meal 11.4 ± 3/9 times per 15-day period. They gave themselves 8.9 ± 3.6 injections of insulin lispro during the same period of time. Controls ate 14.4 ± 0.6 afternoon meals during the same 15-day period.

        Insulin lispro treatment resulted in a significantly lower before-dinner blood glucose level of 10.4 ± 3.8 millimoles/litre (mmol/L) in the treated group compared with 14.7 ± 3.9 mmol/L in the control group.

        Treatment with insulin lispro also reduced the number of days that blood glucose was over 10 mmol/L by 50%.

        In boys, the change in haemoglobin A1c from baseline to endpoint showed a slight but significant difference between treated and untreated groups. Haemoglobin A1c increased significantly in all patients with the number of meals taken without a corresponding injection.

        Frequency of hypoglycaemia and changes in weight were similar between the two groups.

        The investigators conclude that insulin lispro taken before an afternoon meal can lower before dinner blood glucose levels. It may also lower haemoglobin A1c in boys, they add.
        Diabet Med 2002;19:12:1026-1031. "Efficacy of Humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send